EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lacosamide prevents cyclophosphamide-induced testicular dysfunction via inhibition of NF-κB/IL-6/STAT-3 and JNK1/Caspase-3 axes with AR and HO-1 preservation: in vivo and in silico evidence

Mohammed R A Ali, Basim A S Messiha, Ahmed S Abdel-Samea, Mina Ezzat Attya, Reham H Mohyeldin

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-026-04994-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Mohammed R A Ali und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, 62514, Egypt. ragab_2000006@pharm.bsu.edu.eg. Hauptthemen laut MEDLINE: Cyclophosphamide, Testis. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EUN Egyptian Universities Network.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigated lacosamide (LCM), a third-generation antiepileptic drug, as a potential gonadoprotective agent against cyclophosphamide (CP)-induced testicular injury. The research addressed the critical need for safer antiepileptic alternatives in cancer patients requiring concurrent chemotherapy and seizure control. Male Wistar rats underwent comprehensive biochemical and histopathological analyses including Western blot, quantitative reverse transcription polymerase chain reaction (qRT-PCR), immunohistochemistry, steroidogenic enzyme activity assessments, sexual hormone measurements, sperm quality evaluations, and molecular docking studies to evaluate LCM's protective mechanisms against CP-induced testicular damage. CP administration significantly elevated oxidative stress markers, pro-inflammatory mediators (Nuclear factor kappa B [NF- κ B], Tumor necrosis factor-α [TNF-α], Interleukin-6 [IL-6], Interleukin-1β [IL-1β]), and apoptotic signaling (Bcl-2-associated x protein [Bax], caspase-3), while activating regulatory proteins c-jun N-terminal kinase 1 (JNK1) and Signal transducer and activator of transcription 3 (STAT-3) (identified as novel markers in CP-induced testicular injury). CP suppressed antioxidant defenses, steroidogenic factors (steroidogenic acute regulatory protein [StAR], 3β-hydroxysteroid dehydrogenase [3β-HSD], 17β-hydroxysteroid dehydrogenase [17β-HSD]), Heme oxygenase 1 (HO-1) expression, and androgen receptor (AR) functionality, resulting in decreased testosterone, gonadotropin levels, and compromised spermatogenesis. LCM treatment effectively mitigated these deleterious effects through multi-target protective mechanisms including c-jun N-terminal kinase 1(JNK1)-mediated apoptosis inhibition, HO-1 upregulation, IL-6/ signal transducer and activator of transcription 3 (STAT-3) signaling suppression, prevention of p-JNK1/STAT-3 crosstalk, and AR preservation. This study establishes LCM's multi-target protective efficacy, supporting its potential as a safer antiepileptic alternative providing dual benefits of seizure control and reproductive preservation during chemotherapy. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyclophosphamideTestisAnimalsMaleSTAT3 Transcription FactorRats, WistarMitogen-Activated Protein Kinase 8Interleukin-6NF-kappa BReceptors, AndrogenHeme Oxygenase-1Signal TransductionCaspase 3RatsMolecular Docking SimulationOxidative StressHeme Oxygenase (Decyclizing)

Stichwörter der Autor:innen

CyclophosphamideHO-1JNK1LacosamideSTAT-3Testes

Substanzen

STAT3 Transcription FactorCyclophosphamideMitogen-Activated Protein Kinase 8Stat3 protein, ratInterleukin-6NF-kappa BReceptors, AndrogenHeme Oxygenase-1Caspase 3Hmox1 protein, rat

Autor:innen und Institutionen

  • Department of Pharmacology & Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, 62514, Egypt. ragab_2000006@pharm.bsu.edu.eg.
  • Department of Pharmacology & Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, 62514, Egypt.
  • Department of Pharmacology & Toxicology, Faculty of Pharmacy, Deraya University, New Minia City, 61111, Egypt.
  • Department of Pathology, Faculty of Medicine, Minia University, Minia, 61519, Egypt.

Förderung

  • EUN Egyptian Universities Network

Zitieren

APA

Ali, M. R. A., Messiha, B. A. S., Abdel-Samea, A. S., Attya, M. E., & Mohyeldin, R. H. (2026). Lacosamide prevents cyclophosphamide-induced testicular dysfunction via inhibition of NF-κB/IL-6/STAT-3 and JNK1/Caspase-3 axes with AR and HO-1 preservation: in vivo and in silico evidence. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-04994-7

Vancouver

Ali MRA, Messiha BAS, Abdel-Samea AS, Attya ME, Mohyeldin RH. Lacosamide prevents cyclophosphamide-induced testicular dysfunction via inhibition of NF-κB/IL-6/STAT-3 and JNK1/Caspase-3 axes with AR and HO-1 preservation: in vivo and in silico evidence. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-04994-7

BibTeX
@article{Ali2026,
  author = {Ali, Mohammed R A and Messiha, Basim A S and Abdel-Samea, Ahmed S and Attya, Mina Ezzat and Mohyeldin, Reham H},
  title = {Lacosamide prevents cyclophosphamide-induced testicular dysfunction via inhibition of NF-κB/IL-6/STAT-3 and JNK1/Caspase-3 axes with AR and HO-1 preservation: in vivo and in silico evidence},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-026-04994-7}
}
Kostenlos starten →